(1)
Generation of a Colony of Homozygous K18-HACE2 Transgenic Mice for the Evaluation of Vaccine and Therapeutic Candidates Against SARS-CoV-2. FAVET 2022, 20 (Suppl.), 31-39. https://doi.org/10.14409/favecv.v20iSuppl. 11212.